---
figid: PMC7564545__vaccines-08-00422-g002
figlink: pmc/articles/PMC7564545/figure/vaccines-08-00422-f002/
number: F2
caption: 'Interplay between innate immunity and hepatitis E virus (HEV). Double-stranded
  (ds) HEV RNA is detected in the cytoplasm by retinoic acid-inducible gene I (RIG-I)
  and melanoma differentiation-associated protein 5 (MDA5), leading to type I and
  type III interferon (IFN) production. TLR3 detects HEV RNA in the endosomal compartment.
  The protease domain (Pro) of the ORF1 protein inhibits signaling via RIG-I and prevents
  IFN induction by removing ubiquitin from RIG-I and TANK binding kinase 1 (TBK-1).
  Pro and Met can also interfere with the MDA5 signaling pathway. The methyltransferase
  domain (Met) also acts on RIG-I to reduce IFN production, and interferes with ferritin
  secretion to decrease the inflammatory response. The X domain (X) and the capsid
  protein ORF2 inhibit the phosphorylation (P) of IFN regulatory protein 3 (IRF3).
  Conversely, the ORF3 protein stimulates the direct production of type I IFN via
  RIG-I, while ORF3 interferes with TLR3 synthesis. ORF3 and part of ORF1 (methyltransferase
  + Y domain + Protease: Met-Y-Pro) also bind to STAT1 to restrict its phosphorylation
  and the activation of the downstream cascade, thus inhibiting IFN-stimulated gene
  (ISG) expression, including that of “interferon-induced protein with tetratricopeptide
  repeats 1” (IFIT1) and ISG15. Abbreviations include IKKε: IκB-kinase-epsilon; IRF3,
  7 or 9: IFN regulatory protein 3, 7 or 9; ISRE: interferon-stimulated response element;
  MAVS: mitochondrial antiviral-signaling protein; STAT1 or 2: signal transducer and
  activator of transcription 1 or 2; and Ub: ubiquitin.'
pmcid: PMC7564545
papertitle: 'Hepatitis E Virus: How It Escapes Host Innate Immunity.'
reftext: Sébastien Lhomme, et al. Vaccines (Basel). 2020 Sep;8(3):422.
pmc_ranked_result_index: '16253'
pathway_score: 0.9679239
filename: vaccines-08-00422-g002.jpg
figtitle: Interplay between innate immunity and hepatitis E virus (HEV)
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7564545__vaccines-08-00422-g002.html
  '@type': Dataset
  description: 'Interplay between innate immunity and hepatitis E virus (HEV). Double-stranded
    (ds) HEV RNA is detected in the cytoplasm by retinoic acid-inducible gene I (RIG-I)
    and melanoma differentiation-associated protein 5 (MDA5), leading to type I and
    type III interferon (IFN) production. TLR3 detects HEV RNA in the endosomal compartment.
    The protease domain (Pro) of the ORF1 protein inhibits signaling via RIG-I and
    prevents IFN induction by removing ubiquitin from RIG-I and TANK binding kinase
    1 (TBK-1). Pro and Met can also interfere with the MDA5 signaling pathway. The
    methyltransferase domain (Met) also acts on RIG-I to reduce IFN production, and
    interferes with ferritin secretion to decrease the inflammatory response. The
    X domain (X) and the capsid protein ORF2 inhibit the phosphorylation (P) of IFN
    regulatory protein 3 (IRF3). Conversely, the ORF3 protein stimulates the direct
    production of type I IFN via RIG-I, while ORF3 interferes with TLR3 synthesis.
    ORF3 and part of ORF1 (methyltransferase + Y domain + Protease: Met-Y-Pro) also
    bind to STAT1 to restrict its phosphorylation and the activation of the downstream
    cascade, thus inhibiting IFN-stimulated gene (ISG) expression, including that
    of “interferon-induced protein with tetratricopeptide repeats 1” (IFIT1) and ISG15.
    Abbreviations include IKKε: IκB-kinase-epsilon; IRF3, 7 or 9: IFN regulatory protein
    3, 7 or 9; ISRE: interferon-stimulated response element; MAVS: mitochondrial antiviral-signaling
    protein; STAT1 or 2: signal transducer and activator of transcription 1 or 2;
    and Ub: ubiquitin.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNA1
  - TYK2
  - JAK3
  - SLTM
  - IFIH1
  - DDX58
  - STAT1
  - STAT2
  - MAVS
  - TLR3
  - IKBKE
  - TBK1
  - IRF3
  - IRF7
  - IFIT1
  - ISG15
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - ASS1
  - IRF9
genes:
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAKI
  symbol: JAKL
  source: hgnc_alias_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: Met
  symbol: Met
  source: hgnc_alias_symbol
  hgnc_symbol: SLTM
  entrez: '79811'
- word: Met
  symbol: Met
  source: hgnc_alias_symbol
  hgnc_symbol: SLTM
  entrez: '79811'
- word: MDA5
  symbol: MDA5
  source: hgnc_alias_symbol
  hgnc_symbol: IFIH1
  entrez: '64135'
- word: RIG-I
  symbol: RIG-I
  source: hgnc_alias_symbol
  hgnc_symbol: DDX58
  entrez: '23586'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT2
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: MAVS
  symbol: MAVS
  source: hgnc_symbol
  hgnc_symbol: MAVS
  entrez: '57506'
- word: Met
  symbol: Met
  source: hgnc_alias_symbol
  hgnc_symbol: SLTM
  entrez: '79811'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: TLR3
  symbol: TLR3
  source: hgnc_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: IKKE
  symbol: IKKE
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKE
  entrez: '9641'
- word: TBK-1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: STAT2
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: IRF7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: IFIT1
  symbol: IFIT1
  source: hgnc_symbol
  hgnc_symbol: IFIT1
  entrez: '3434'
- word: IRF3/7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: IRF3/7
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: ISG15
  symbol: ISG15
  source: hgnc_symbol
  hgnc_symbol: ISG15
  entrez: '9636'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: aß/A
  symbol: ASS
  source: hgnc_prev_symbol
  hgnc_symbol: ASS1
  entrez: '445'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IRF9
  symbol: IRF9
  source: hgnc_symbol
  hgnc_symbol: IRF9
  entrez: '10379'
chemicals: []
diseases: []
figid_alias: PMC7564545__F2
redirect_from: /figures/PMC7564545__F2
figtype: Figure
---
